Viewing Study NCT07239102


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-03-11 @ 1:02 AM
Study NCT ID: NCT07239102
Status: COMPLETED
Last Update Posted: 2025-11-20
First Post: 2025-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
Sponsor: Beijing Tiantan Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None EGFR Positive Non-small Cell Lung Cancer View
None Central Nervous System Metastasis View
None Leptomeningeal Metastasis View
Keywords: